GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (OTCPK:FSPKF) » Definitions » 3-Year EPS without NRI Growth Rate

Fisher & Paykel Healthcare (Fisher & Paykel Healthcare) 3-Year EPS without NRI Growth Rate : -4.60% (As of Sep. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Fisher & Paykel Healthcare 3-Year EPS without NRI Growth Rate?

Fisher & Paykel Healthcare's EPS without NRI for the six months ended in Sep. 2023 was $0.11.

During the past 12 months, Fisher & Paykel Healthcare's average EPS without NRI Growth Rate was 3.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was -4.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 11.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 16.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Fisher & Paykel Healthcare was 76.20% per year. The lowest was -17.00% per year. And the median was 13.50% per year.


Competitive Comparison of Fisher & Paykel Healthcare's 3-Year EPS without NRI Growth Rate

For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fisher & Paykel Healthcare's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Fisher & Paykel Healthcare's 3-Year EPS without NRI Growth Rate falls into.



Fisher & Paykel Healthcare 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Fisher & Paykel Healthcare  (OTCPK:FSPKF) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Fisher & Paykel Healthcare 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Fisher & Paykel Healthcare (Fisher & Paykel Healthcare) Business Description

Traded in Other Exchanges
Address
15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.

Fisher & Paykel Healthcare (Fisher & Paykel Healthcare) Headlines

From GuruFocus

Fisher & Paykel Healthcare Corp Ltd's Dividend Analysis

By GuruFocus Research 12-04-2023